Qualisure News We are presenting at the 2024 American Association of Endocrine Sugeons Annual Meeting - Dallas, TX April 20-22, 2024 - Come see us! LEARN MORE IN THE NEWS PRESS RELEASES EVENTS AND CONFERENCES Search Search Unique Thyroid Cancer Tests: New Hope Unveiled Read More > A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023] Read More > Oliver Bathe: Qualisure Diagnostics Developing State-Of-The-Art Diagnostic Tests That Help To Personalize Cancer Care Read More > From doctor to entrepreneur – Oliver Bathe from Qualisure Diagnostics Read More > Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022] Read More > 2022 American Thyroid Association – Dr. Oliver Bathe Read More > Qualisure Diagnostics: An AICE-Validate Success Story Read More > Precision Oncology Test Thyroid GuidePx® Now Available From Qualisure Diagnostics Read More > Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021] Read More > Dr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists Read More > READ MORE The Technological Drivers Powering Precision Oncology Unique Thyroid Cancer Tests: New Hope Unveiled Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]
A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]